Loading... Please wait...
App Store Download on the App Store Google Play GET IT ON Google Play

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Analyst Forecast

Currency in USD Disclaimer
Add to Alerts
Add to Watchlist
$20.09 -$0.6 (-2.9%)
$19.84
$20.99
$13.27
$22

  • Consensus Price Target

    $29.50

    46.84% Upside

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside on Report Date Details
04/30/2024 RBC Capital Brian Abrahams $30.00 $16.00   87.5%
04/29/2024 Stifel Nicolaus Paul Matteis $29.00 $16.00   81.25%

Contineum Therapeutics, Inc. Class A Common Stock Frequently Asked Questions

  • Q. What analysts cover Contineum Therapeutics, Inc. Class A Common Stock?

    A. Contineum Therapeutics, Inc. Class A Common Stock has been rated by research analysts at RBC Capital, Stifel Nicolaus in the past 90 days.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In

or
Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Sign Up With Email Address
or
Continue with Google Continue with Apple

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.